Design and Evaluation of a Carrier-Free Prodrug-Based Palmitic–DEVD–Doxorubicin Conjugate for Targeted Cancer Therapy-Reference-Cited by-同舟云学术

Design and Evaluation of a Carrier-Free Prodrug-Based Palmitic–DEVD–Doxorubicin Conjugate for Targeted Cancer Therapy

Author:

Yang Seong-Bin¹,Lee Dong-Nyeong¹,Lee Jun-Hyuck²,Seo Minho²,Shin Dong Wook³,Lee Seokwoo⁴,Lee Young-Ho⁵⁶⁷^ORCID,Park Jooho¹²^ORCID

Affiliation:

1. Department of Applied Life Science, Graduate School, BK21 Program, Konkuk University, Chungju 27478, Republic of Korea

2. Department of Biomedical Chemistry, College of Biomedical and Health Science, Konkuk University, Chungju 27478, Republic of Korea

3. College of Biomedical and Health Science, Konkuk University, Chungju 27478, Republic of Korea

4. College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea

5. Research Center for Bioconvergence Analysis, Korea Basic Science Institute (KBSI), Ochang, Chungbuk 28119, Republic of Korea

6. Bio-Analytical Science, University of Science and Technology, Daejeon 34113, Republic of Korea

7. Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon 34134, Republic of Korea

Funder

National Research Council of Science and Technology

National Research Foundation of Korea

Korea Basic Science Institute

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

Reference56 articles.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献